Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern

Journal of Pharmacological and Toxicological Methods
Glenn E KirschArthur M Brown

Abstract

In vitro evaluation of drug effects on hERG K(+) channels is a valuable tool for identifying potential proarrhythmic side effects in drug safety testing. Patch-clamp recording of hERG K(+) current in mammalian cells can accurately evaluate drug effects, but the methodology has not been standardized, and results vary widely. Our objective was to evaluate two potential sources of variability: the temperature at which recordings are performed and the voltage pulse protocol used to activate hERG K(+) channels expressed in HEK293 cells. A panel of 15 drugs that spanned a broad range of potency for hERG inhibition and pharmacological class was evaluated at both room and near-physiological temperatures using several patch-clamp voltage protocols. Concentration-response analysis was performed with three stimulus protocols: 0.5- and 2-s step pulses, or a step-ramp pattern. Block by 2 of the 15 drugs tested, d,l-sotalol (antiarrhythmic) and erythromycin (antibiotic), was markedly temperature sensitive. hERG inhibition measured using a 2-s step-pulse protocol underestimated erythromycin potency compared with results obtained with a step-ramp protocol. Using conservative acceptance criteria and the step-ramp protocol, the IC(50) values for...Continue Reading

References

Nov 1, 1989·The Journal of Antimicrobial Chemotherapy·M IshiguroM Hirota
Nov 1, 1995·Journal of Cardiovascular Pharmacology·B Le GrandG W John
Feb 24, 1999·Journal of Cardiovascular Pharmacology·S S PoP B Bennett
Aug 12, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Y G Yap, A J Camm
Apr 14, 2000·European Journal of Pharmacology·J KangD Rampe
Nov 25, 2000·Circulation Research·H NumaguchiJ R Balser
Apr 19, 2002·The Journal of Pharmacology and Experimental Therapeutics·Sean EkinsSteven A Wrighton
Jun 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Walter A VolbergJun Zhou
Aug 15, 2002·European Journal of Pharmacology·Sathapana KongsamutDavid Rampe
Oct 22, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Jixin WangJoseph J Salata
Aug 9, 2003·The Journal of Pharmacy and Pharmacology·Erika HanadaTatsuji Iga

❮ Previous
Next ❯

Citations

May 7, 2014·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Barbara WiśniowskaSebastian Polak
Jun 14, 2008·The Journal of Clinical Investigation·Ahmad S AminArthur A M Wilde
Apr 9, 2009·Annals of Biomedical Engineering·Qinlian ZhouJeffrey J Fox
Sep 17, 2009·Pflügers Archiv : European journal of physiology·Yau-Chi ChanRonald A Li
Jun 14, 2005·Current Opinion in Chemical Biology·Glenn A ReinhartGary A Gintant
Aug 5, 2008·European Biophysics Journal : EBJ·Arthur M Brown
Mar 2, 2006·Assay and Drug Development Technologies·Khuram W ChaudharyAnthony Bahinski
Jun 7, 2005·Journal of Pharmacological and Toxicological Methods·Liang Guo, Heather Guthrie
Jun 7, 2005·Journal of Pharmacological and Toxicological Methods·Jian-An YaoPhilip Atterson
Jun 14, 2005·Journal of Pharmacological and Toxicological Methods·Barbara A WibleArthur M Brown
Jan 8, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·Eva ZebedinKarlheinz Hilber
Feb 15, 2007·Expert Opinion on Therapeutic Targets·Harry J Witchel
Mar 22, 2007·Expert Opinion on Therapeutic Targets·Cecilia FarreNiels Fertig
Oct 6, 2007·Expert Opinion on Drug Metabolism & Toxicology·Jianling WangDejan Bojanic
Apr 18, 2012·Expert Opinion on Drug Discovery·Cecilia Farre, Niels Fertig
Jul 4, 2009·Expert Opinion on Drug Metabolism & Toxicology·Emanuel RaschiMaurizio Recanatini
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Phillip J StansfeldJohn S Mitcheson
Feb 20, 2016·Nature Reviews. Drug Discovery·Gary GintantNorman Stockbridge
Aug 15, 2015·Clinical Pharmacology and Therapeutics·F SalvoUNKNOWN Investigators of the ARITMO Consortium
Oct 30, 2012·Journal of Pharmacological and Toxicological Methods·Daniel J GillieClaire Townsend
Jan 13, 2011·Journal of Pharmacological and Toxicological Methods·Pascal ChamperouxJean-Yves Le Guennec
Feb 23, 2010·Journal of Pharmacological and Toxicological Methods·James T MilnesJules C Hancox
Jan 13, 2010·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Jian-Yong Qian, Liang Guo
Jun 2, 2009·Journal of Neuroscience Methods·Serguei S SidachMerouane Bencherif
Dec 17, 2015·BMC Pharmacology & Toxicology·Yuji HaraguchiTatsuya Shimizu
Dec 9, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·T BrennanB Rodriguez
Jul 12, 2008·Pharmacology & Therapeutics·Jules C HancoxYi Hong Zhang
Aug 12, 2015·Toxicological Sciences : an Official Journal of the Society of Toxicology·Mike ClementsSian Kalinka
Feb 14, 2006·British Journal of Pharmacology·Ari J AlexandrouJoanne L Leaney
Dec 17, 2008·British Journal of Clinical Pharmacology·Emanuel RaschiFabrizio De Ponti
Apr 21, 2007·Proteins·Phillip J StansfeldMichael J Sutcliffe
Jun 27, 2007·British Journal of Pharmacology·D StorkS Hering
Apr 1, 2011·British Journal of Pharmacology·N Abi-GergesG A Robertson
Apr 25, 2012·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Deena AbabnehWilliam S Webster
Jul 5, 2012·Journal of Applied Toxicology : JAT·Barbara WiśniowskaSebastian Polak
Jan 17, 2014·Cardiovascular Therapeutics·Elsayed Abo-SalemKenneth Nugent
Oct 13, 2009·Journal of Cardiovascular Electrophysiology·Antonio E LacerdaArthur M Brown
Feb 1, 2008·IEEE Transactions on Bio-medical Engineering·David G RandJeffrey J Fox

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.